csirt@kutim:~/threat-intel/cve/CVE-2021-37659

Katalog CVE

CVSS 7.8 · High EPSS 0,18%

Kerentanan Out-of-bounds Read pada google tensorflow. Skor CVSS 3.1 7.8 (High) menurut NVD.

Deskripsi (NVD)

TensorFlow is an end-to-end open source platform for machine learning. In affected versions an attacker can cause undefined behavior via binding a reference to null pointer in all binary cwise operations that don't require broadcasting (e.g., gradients of binary cwise operations). The [implementation](https://github.com/tensorflow/tensorflow/blob/84d053187cb80d975ef2b9684d4b61981bca0c41/tensorflow/core/kernels/cwise_ops_common.h#L264) assumes that the two inputs have exactly the same number of elements but does not check that. Hence, when the eigen functor executes it triggers heap OOB reads and undefined behavior due to binding to nullptr. We have patched the issue in GitHub commit 93f428fd1768df147171ed674fee1fc5ab8309ec. The fix will be included in TensorFlow 2.6.0. We will also cherrypick this commit on TensorFlow 2.5.1, TensorFlow 2.4.3, and TensorFlow 2.3.4, as these are also affected and still in supported range.

Rincian

Terbit di NVD
12 Agustus 2021
Terakhir diubah
17 Juni 2026
Status NVD
Modified
CVSS 3.1
7.8 (High), sumber NVD
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-125: Out-of-bounds Read
CWE-476: NULL Pointer Dereference
EPSS (30 hari)
0,18% peluang dieksploitasi; lebih tinggi dari 6,6% CVE lain

Produk dan versi terdampak

VendorProdukVersi terdampak
google tensorflow Versi 2.3.0 hingga sebelum 2.3.4
google tensorflow Versi 2.4.0 hingga sebelum 2.4.3
google tensorflow Versi 2.5.0
google tensorflow Versi 2.6.0 rc0
google tensorflow Versi 2.6.0 rc1
google tensorflow Versi 2.6.0 rc2

> Data dari konfigurasi CPE di NVD.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:10 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.